Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Protons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Meningioma 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Ion Beam Radiation Therapy for Tumor Patients 1 Gastroesophageal Junction Adenocarcinoma 1 Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Doxorubicin 14 pembrolizumab 9 Gemcitabine 8 Surgical Procedures, Operative 7 Nivolumab 6 Blood Specimen Collection 6 Trabectedin 5 Surveys and Questionnaires 5 Ifosfamide 5 Drug Therapy 5 Cyclophosphamide 5 Radiotherapy 4 Radiation Dose Hypofractionation 4 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Ipilimumab 3 Docetaxel 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2 pazopanib 2 fluzoparib 2 fludarabine phosphate 2 eribulin 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04946357 2026-03-10

EXTREM ION

University Hospital Heidelberg

Phase NA Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡